Industry News
Imaging chemical elements in bird feathers
ANSTO researchers have been using X-ray imaging on the feathers of long-distance migratory seabirds. The results of their study could lead to important new insights into the evolution and health of birds. [ + ]
Designer viruses to fight cancer
Scientists have created designer viruses that alert the immune system and cause it to send killer cells to help fight cancer. [ + ]
Putting brakes on cancer's ability to spread
US researchers have discovered a biochemical signalling process that causes densely packed cancer cells to break away from a tumour and spread the disease elsewhere in the body. [ + ]
The different mutations behind acute myeloid leukaemia
UK researchers have made a breakthrough in understanding how different genetic mutations cause acute myeloid leukaemia (AML) — one of the most common acute leukaemias in adults. [ + ]
Cutting-edge genomics sequencer arrives in Brisbane
The city of Brisbane has become home to what is claimed to be the world's most advanced genomics sequencer. [ + ]
Australia, Japan team up for advanced cancer treatment
ANSTO, the Centre for Medical Radiation Physics at the University of Wollongong and the National Institute of Radiological Sciences (NIRS), Japan, have partnered to deliver advanced cancer treatment, based on carbon ion therapy. [ + ]
Antibodies found to control seizures in epileptic mice
Japanese researchers have reported the effect of a particular type of monoclonal antibody on epilepsy in mice, with promising results. [ + ]
Whole genome sequencing to diagnose kidney disease
Dr Amali Mallawaarachchi has been awarded a grant by PKD Foundation Australia to support the development of an improved genomic diagnostic tool for individuals with kidney disease. [ + ]
Preventing excessive platelet production in diabetics
Researchers have uncovered a novel mechanism behind excessive platelet production present in people with diabetes, placing them at increased risk of cardiovascular complications such as heart attack and stroke. [ + ]
Blocking the stress hormone: Phase II Alzheimer's trial underway
Actinogen Medical has recruited and treated the first patient as part of its Phase II clinical trial of Xanamem, the biotech company's cortisol-blocking drug. [ + ]
21 scientists join the Academy of Science
The Australian Academy of Science has inducted 21 of Australia's best scientists for their outstanding contributions to science. [ + ]
Australian researchers make melanoma breakthrough
Australian researchers have achieved a major breakthrough in the fight against advanced melanoma, giving hope to over 1800 Australians expected to die from the deadly disease this year. [ + ]
Promoting next-gen cancer research
Leaders from the Australian Nuclear Science and Technology Organisation (ANSTO), experts from Italy and clinicians from NSW recently met to explore how the full range of particle therapy treatments may be made available to Australians. [ + ]
Merck develops new genome editing tool
Science and technology company Merck has developed a new genome editing tool that is said to make CRISPR more efficient, flexible and specific. [ + ]
Nominations open for GSK Award for Research
Nominations for GSK's Award for Research Excellence are now open until 10 July 2017. [ + ]

